Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Golden-Shell Pharmaceutical is a leading global manufacturer specializing in the production of chitin and chitosan derivatives, primarily for the pharmaceutical, nutraceutical, and food industries. Established in 1994 and headquartered in Yuhuan, China, the company is one of the world's largest producers of glucosamine and chitosan, which are widely used in treatments for osteoarthritis and joint health. The company operates large-scale manufacturing facilities that adhere to international quality standards, including GMP, ISO, and HACCP certifications. Beyond joint health, Golden-Shell explores applications for its biopolymers in wound dressing, drug delivery, and water treatment. Their business model focuses on high-volume production and global export of active pharmaceutical ingredients (APIs) and health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Golden-Shell.